Switzerland-based MD Biosciences has released results from tests on an 18-day model of arthritis that was induced using the ArthritoMab cocktail of arthritogenic antibodies in Balb/c mice. According to the company, results show significant histological changes in the joint of the arthritis group compared to the normal control group after just 18 days.
More: continued here